Gains in heart health only experienced by higher-income populations
Apr 19, 2024
The 10-year risk for cardiovascular disease remained stagnant at >8% for US adults with the lowest incomes in 1988 to 2018.
Burnout, poor staffing substantially contribute to nurses leaving healthcare
Apr 11, 2024
The authors say that the leading reasons nurses leave healthcare signal opportunities for employers to reattract an existing nurse workforce.
ACC: Gamification plus financial incentives boost physical activity
Apr 11, 2024
Greatest effect seen during both the 12-month intervention and at six-month follow-up among patients at high risk for cardiovascular events
Many older Americans get care outside of doctor’s office, poll finds
Apr 10, 2024
Most people aged 50 to 80 have embraced “doc-in-a-box” strip mall clinics and urgent care centers as a means of getting prompt medical care, a new poll has found.
EPA sets strict limit on PFAS ‘forever chemicals’ in US drinking water
Apr 10, 2024
The Environmental Protection Agency announced Wednesday that it has finalized a first-ever rule that will drastically lower the amount of PFAS, also known as “forever chemicals,” in the nation’s...
ACC: Semaglutide beneficial in obesity-related heart failure, type 2 diabetes
Apr 09, 2024
Larger reductions were seen in heart failure-related symptoms and physical limitations for patients with HFpEF and type 2 diabetes.
Millions in United States may hear gunshots at night
Apr 09, 2024
An inverse relationship was seen between the number of nighttime gunshots and median household income.
Progressive resistance training not superior for hip osteoarthritis
Apr 08, 2024
Progressive resistance training was not superior to neuromuscular exercise for improving functional performance, hip pain and quality of life.
Distance to neurologist, PCP may explain Alzheimer’s disease disparities
Apr 05, 2024
Non-Hispanic American Indian and/or Alaska Native and Hispanic decedents have to travel further to neurologist than non-Hispanic whites.
Lixisenatide reduces motor disability progression in Parkinson’s disease
Apr 04, 2024
Lixisenatide results in less progression of motor disability than placebo at 12 months for individuals with early Parkinson’s disease.